R adiofrequency catheter ablation of symptomatic arrhythmias has enjoyed unprecedented growth during the past 2 decades. This has been attributed to its high success rate in the treatment of a variety of arrhythmias with a discrete ablation target and the low complication rate observed in these procedures.1,2 Initial investigators performing radiofrequency catheter ablation were fortunate that the lesions created with this energy source were small and discrete. It was difficult to cause excessive collateral injury. Early recognition of the problem of sudden electric impedance rise and coagulum formation 3 led to a number of strategies and technologies to minimize this occurrence. In contrast to supraventricular tachycardia ablation, catheter ablation of atrial fibrillation has pushed the limits of our ablation technologies and has shifted the ratio of efficacy to risk in an unfavorable direction. 4 Aggressive ablation with extensive linear ablation, ablation of complex fractionated atrial electrograms, and empirical isolation (debulking) of the posterior left atrial wall 5 have improved procedural success in patients with persistent atrial fibrillation. But with a greater volume of myocardial injury and a greater surface area of disrupted left atrial endocardium from the ablation, it is not surprising that procedure-related complications, especially embolic complications, are more prevalent.
Article see p 473The initial observations of the appearance of new asymptomatic cerebral embolism (ACE) lesions on diffusion-weighted MR imaging scans after radiofrequency catheter ablation of atrial fibrillation were striking 6,7 but should not have been unanticipated. The ACE lesions observed are attributed to cerebral microembolism and have been widely reported after procedures, such as cardiopulmonary bypass, 8 carotid artery stenting, 9 and trans aortic valve replacement. 10 The fact that ACE lesions have not been reported previously with radiofrequency ablation either has been because of good fortune or simply because of our failure to look. In any case, the issue is now upon us, and it is incumbent on us to define the source of ACE lesions and do the best to mitigate this risk going forward.In this issue of Circulation Arrhythmia and Electro physiology, Nagy-BalĂł et al 11 describe the occurrence of microembolic signals (MES) on transcranial Doppler during pulmonary vein isolation for the treatment of atrial fibrillation catheter ablation using 2 different ablation technologies and 2 different anticoagulation regimens. They observed that the prevalence of MES was lower in patients being ablated with a cryoballoon ablation catheter compared with patients ablated with a multipolar duty cycle radiofrequency pulmonary vein ablation catheter (PVAC). The difference was specifically attributable to higher MES production during the period of radiofrequency energy delivery with the PVAC compared with the period of cryothermy with the cryoballoon. It is difficult to know whether the higher rate of MES with PVAC might or might no...